If we miss even one of these pillars, we will not be able to achieve TB elimination," added Dr Burhan. And we have to find, treat and prevent TB in a people-centred, rights-based and gender ...

Segment featuring members of the CNS management team and leading Neuro-Oncologist and Key Opinion Leader, Dr. Samuel Goldlust Access the segment here HOUSTON, TX / ACCESSWIRE / October 10 ...

Minoryx Therapeutics, a late-stage biotech company focused on the development of therapies for orphan central nervous system (CNS) disorders and Neuraxpharm Group (Neuraxpharm), a leading European ...

Jude Law was joined by two of his oldest children as he was honored with the unveiling of his star on the Hollywood Walk of ...

AbbVie has announced that it has completed its acquisition of Aliada Therapeutics. With the completion of the acquisition, ...

A man and a woman suspected of ambushing and fatally shooting a doctor after he left his medical practice in Woodland Hills ...

The stories we hear during Christmas are filled with messages of hope and optimism; “Don’t give up,” “Keep going,” no matter ...

Median overall survival (OS) to date of 13.4 months for Phase 2 patients treated with the Phase 3 formulation (15.6 months ...

Advance Best-In-Class Treatment Across CNS, Emergency Use Treatments, & Infectious Diseases & Secure Long-Term Funding in ...

The BBC's probe into Diary of a CEO has followed an increase in emphasis on health topics by Bartlett that, according to the broadcaster, has resulted in a big increase in viewers and subscribers for ...